211 related articles for article (PubMed ID: 33682475)
21. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for QTc interval prolongation.
Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
[TBL] [Abstract][Full Text] [Related]
23. AI-Assisted QT Measurements for Highly Automated Drug Safety Studies.
Diaw MD; Papelier S; Durand-Salmon A; Felblinger J; Oster J
IEEE Trans Biomed Eng; 2023 May; 70(5):1504-1515. PubMed ID: 36355743
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.
Tisdale JE; Jaynes HA; Kingery JR; Overholser BR; Mourad NA; Trujillo TN; Kovacs RJ
Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):381-90. PubMed ID: 24803473
[TBL] [Abstract][Full Text] [Related]
25. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
Castelletti S; Dagradi F; Goulene K; Danza AI; Baldi E; Stramba-Badiale M; Schwartz PJ
Int J Cardiol; 2018 Sep; 266():89-94. PubMed ID: 29887480
[TBL] [Abstract][Full Text] [Related]
26. Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System.
Anderson HN; Bos JM; Haugaa KH; Morlan BW; Tarrell RF; Caraballo PJ; Ackerman MJ
Pediatr Cardiol; 2015 Oct; 36(7):1350-6. PubMed ID: 25845942
[TBL] [Abstract][Full Text] [Related]
27. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model.
Vandael E; Vandenberk B; Vandenberghe J; Van den Bosch B; Willems R; Foulon V
Br J Clin Pharmacol; 2018 Dec; 84(12):2824-2835. PubMed ID: 30112769
[TBL] [Abstract][Full Text] [Related]
28. Drug-Induced QTc Prolongation.
Riad FS; Davis AM; Moranville MP; Beshai JF
Am J Cardiol; 2017 Jan; 119(2):280-283. PubMed ID: 28126150
[TBL] [Abstract][Full Text] [Related]
29. Remote Monitoring of the QT Interval and Emerging Indications for Arrhythmia Prevention.
Castelletti S; Winkel BG; Schwartz PJ
Card Electrophysiol Clin; 2021 Sep; 13(3):523-530. PubMed ID: 34330378
[TBL] [Abstract][Full Text] [Related]
30. Which QT Correction Formulae to Use for QT Monitoring?
Vandenberk B; Vandael E; Robyns T; Vandenberghe J; Garweg C; Foulon V; Ector J; Willems R
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317349
[TBL] [Abstract][Full Text] [Related]
31. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
32. Assessment of drug-induced QT interval prolongation in conscious rabbits.
Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of ECG leads used to assess QT prolongation.
Sadanaga T; Sadanaga F; Yao H; Fujishima M
Cardiology; 2006; 105(3):149-54. PubMed ID: 16449814
[TBL] [Abstract][Full Text] [Related]
34. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
35. Predictors of mortality in high-risk patients with QT prolongation in a community hospital.
Gibbs C; Thalamus J; Heldal K; Holla ØL; Haugaa KH; Hysing J
Europace; 2018 Jun; 20(FI1):f99-f107. PubMed ID: 29036623
[TBL] [Abstract][Full Text] [Related]
36. Applying interpretable deep learning models to identify chronic cough patients using EHR data.
Luo X; Gandhi P; Zhang Z; Shao W; Han Z; Chandrasekaran V; Turzhitsky V; Bali V; Roberts AR; Metzger M; Baker J; La Rosa C; Weaver J; Dexter P; Huang K
Comput Methods Programs Biomed; 2021 Oct; 210():106395. PubMed ID: 34525412
[TBL] [Abstract][Full Text] [Related]
37. "QT clock" to improve detection of QT prolongation in long QT syndrome patients.
Page A; Aktas MK; Soyata T; Zareba W; Couderc JP
Heart Rhythm; 2016 Jan; 13(1):190-8. PubMed ID: 26334569
[TBL] [Abstract][Full Text] [Related]
38. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
[TBL] [Abstract][Full Text] [Related]
39. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs.
Berger FA; van der Sijs H; van Gelder T; Kuijper AFM; van den Bemt PMLA; Becker ML
Int J Med Inform; 2021 Jan; 145():104329. PubMed ID: 33181445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
